Arcus Biosciences, Inc. · NYSE:RCUS

Gilead Sciences, Inc. reported a 35.00% stake in Arcus Biosciences, Inc. (Schedule 13D/A)

Event Feb 18, 2025 · Filed Feb 20, 2025

Gilead Sciences, Inc. reported a 35.00% stake in Arcus Biosciences, Inc., 39,691,649 shares, with active intent on Feb 18, 2025. Filed Feb 20, 2025 (Schedule 13D/A).

Stake
35.00%
Shares
39,691,649
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
GILEAD SCIENCES, INC.35.00%39,691,649

Source

View original at SEC

Related